• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Bayer

Bayer cross
Marketing

Melissa explains it all in menopause team up with Bayer

Bayer is teaming up with Melissa Joan Hart to boost awareness about hot flashes treatment Lynkuet by tapping her personal experiences.
Ben Adams Oct 8, 2026 9:24am
Bayer Bayer Ohio New Albany

Bayer doubles down on US with $2.2B Ohio manufacturing project

Oct 2, 2026 3:10pm
Stivarga

Bayer sells cancer drug Stivarga to Grünenthal for up to $431M

Sep 21, 2026 10:20am
FDA approved stamp regulations yes go

Bayer’s Kerendia scores FDA nod for CKD in Type 1 diabetes

Sep 17, 2026 2:06pm
Bayer cross

FDA christens Hyrnuo a first-line option for rare lung cancer

Sep 9, 2026 4:33pm
Bayer Bill Anderson

Bayer CEO Anderson sticking out firm's revitalization scheme

Aug 4, 2026 10:40am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings